Liver sinusoidal endothelial cells (LSECs) are liver-specific endothelial cells with the highest permeability than other mammalian endothelial cells, characterized by the presence of fenestrae on their surface, the absence of diaphragms and the lack of basement membrane. Located at the interface between blood and other liver cell types, LSECs mediate the exchange of substances between the blood and the Disse space, playing a crucial role in maintaining substance circulation and homeostasis of multicellular communication. As the initial responders to chronic liver injury, the abnormal LSEC activation not only changes their own physicochemical properties but also interrupts their communication with hepatic stellate cells and hepatocytes, which collectively aggravates the process of liver fibrosis. In this review, we have comprehensively updated the various pathways by which LSECs were involved in the initiation and aggravation of liver fibrosis, including but not limited to cellular phenotypic change, the induction of capillarization, decreased permeability and regulation of intercellular communications. Additionally, the intervention effects and latest regulatory mechanisms of anti-fibrotic drugs involved in each aspect have been summarized and discussed systematically. As we studied deeper into unraveling the intricate role of LSECs in the pathophysiology of liver fibrosis, we unveil a promising horizon that pave the way for enhanced patient outcomes.
Citations
Citations to this article as recorded by
Dark tea ameliorates liver fibrosis via FXR/TGR5-mediated intestinal permeability and liver sinusoidal capillarization Chen-Yu Wang, Sen Liu, Chong Gao, Xu Dai, Li-Hua Lian, Zhen-Yu Cui, Ji-Xing Nan, Yan-Ling Wu Journal of Ethnopharmacology.2026; 354: 120537. CrossRef
Targeting LOXL1-expressing Hepatic Stellate Cell Inhibits Fibrogenesis and Sinusoid Angiogenesis via LOXL1/RUNX1/VEGFA Axis During Progression of Liver Fibrosis Xuzhen Yan, Qi Han, Yiwen Wang, Weiyu Li, Ning Zhang, Xu Fan, Wei Chen, Hong You, Aiting Yang Cellular and Molecular Gastroenterology and Hepatology.2026; 20(2): 101637. CrossRef
Spatial patterning strategies for liver tissue engineering: Biofabrication technologies and applications Haram Nah, Ashlin R. Michell, Kerry M. Rogy, Owen J. Lally, Salman R. Khetani Advanced Drug Delivery Reviews.2026; 228: 115737. CrossRef
Precision Targeting of Hepatic Stellate Cells: Nanotherapeutic Strategies for Liver Fibrosis Regression Xinying Ma, Dawei Chen, Ming Zhao, Haiyang Hu WIREs Nanomedicine and Nanobiotechnology.2026;[Epub] CrossRef
Hepatic Fibrosis and Liver Cancer Aina Anton, Scott L. Friedman, Bruno Cogliati Seminars in Liver Disease.2026; 46(01): 031. CrossRef
Integrating single-cell RNA sequencing with spatial transcriptomics reveal the fibrosis-related genes in hepatocellular carcinoma Wenying Qiao, Lei Li, Ronghua Jin, Caixia Hu Frontiers in Immunology.2026;[Epub] CrossRef
OGT-enriched Hepatocyte-derived Extracellular Vesicles Promote Capillarization of Liver Sinusoidal Endothelial Cells in Metabolic Dysfunction-associated Steatotic Liver Disease Yanjin Wang, Xulin Zhou, Yu Zhang, Fuji Yang, Yifei Chen, Yanshuang Wu, Lin Zhang, Junfei Tan, Wei Luo, Jing Zhou, Yongmin Yan Cellular and Molecular Gastroenterology and Hepatology.2026; 20(5): 101721. CrossRef
LSEC-derived CXCL9 orchestrates immune recruitment and hepatocyte reprogramming in liver fibrosis Jing Li, Qiannan Di, Xiujuan Zhou, Mengling Chang, Wei Chen Acta Biochimica et Biophysica Sinica.2026;[Epub] CrossRef
Kupffer cells: Orchestrators of liver physiology Qin Cai, Yusi Chen, Li Tang Liver Research.2026; 10(2): 99. CrossRef
HBV reprograms the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic implications Xiaodong Shen, Hechen Huang, Jianpeng Sheng, Xiaofeng Tang Clinical and Experimental Medicine.2026;[Epub] CrossRef
Engineered exosomes from umbilical cord mesenchymal stem cells with pPB modification attenuate hepatic fibrosis via hepatic stellate cell targeting Fanghong Wang, Zongbin Sun, Qiuxia Zheng, Xiaofeng Wei, Lu Zhang, Xiaoliang Zhu, Kexiang Zhu, Xiaojing Song, Ping Yue, Fanghui Ding, Lei Zhang, Xun Li Journal of Translational Medicine.2026;[Epub] CrossRef
Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies Xiangqi Chen, Jinhang Zhang, Ling Guo, Chuan Wu, Jingyue Zhou, Mingzhu Xu, Li Mo, Yanping Li, Jinhan He Signal Transduction and Targeted Therapy.2026;[Epub] CrossRef
The Effect of Somatostatin on Mediators of Liver Inflammation and Fibrosis in Viral Cirrhosis Angeliki Tsakou, George Notas, Constantinos Xidakis, Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis Livers.2026; 6(2): 16. CrossRef
Salvianolic acid C attenuates liver fibrosis and inhibites hepatic stellate cell activation by targeting FAP/TβRI/SMAD axis Tao Sun, Xue Zheng, Liang Li, Jin Chu, Qiang Guo, Ning Yang, Xue Zhang, Xiaotong Li, Bowen Shi, Hongbin Zhang, Guodong Lü, Lufeng Cheng, Renyong Lin, Xiaojuan Bi International Immunopharmacology.2026; 175: 116400. CrossRef
From bench to bedside: Molecular mechanisms, diagnostic tools, and therapeutic strategies in liver fibrosis Zhen Yang, Weizhao Tong, Kanglong Zhang, Guoxin Hu Liver Research.2026; 10(2): 133. CrossRef
Immunotherapy in liver metastases: Challenges, emerging evidence, and future directions Hoang Tran Pham, Zhong-Yi Dong, Margarita De Alba, Chasen Cottle, Ming-Yi Zhang, Joseph B Parker, Renee Morecroft-Phillipps, Keyur Chaludiya, Demarcus Ingram, Ayesha N Ahmad, Zhen Zeng, Michael M Mohseni, Zi-Zhen Zhang, Libardo Rueda Prada, Muhammad Ali, World Journal of Clinical Oncology.2026;[Epub] CrossRef
Endothelial Cell Therapy for the Acute and Chronic Liver Disease Dilnar Mahmut, Valerie Gouon-Evans Seminars in Liver Disease.2026; 46(01): 077. CrossRef
The Role of MicroRNAs in the Progression of Metabolic Dysfunction-associated Steatotic Liver Disease Jang Hyun Choi Journal of Digestive Cancer Research.2026; 14(1): 82. CrossRef
Recent advances in plant-derived exosome-like nanovesicles for the treatment of liver diseases: from natural extracts to precision nanomedicine Siyue Li, Haotian Zhang, Xinyao Zhang, Yaying Wang, Zhi Peng, Lu Yuan, Haoran Wang, Fanxing Xu, Fei Han Chemical Engineering Journal.2026; 539: 176899. CrossRef
Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions Jiaorong Qu, Wenqing Qin, Minghang Dong, Zhi Ma, Si Li, Runping Liu, Ranyun Chen, Changmeng Li, Xiaojiaoyang Li MedComm.2026;[Epub] CrossRef
ROCK2 inhibitor targets vascular niche angiocrine signaling in liver fibrosis Pingxin Sun, Chunyan Wang, Wenlin Li Trends in Pharmacological Sciences.2026; 47(6): 587. CrossRef
Piezo1/2 in fibrosis: Cell-type-specific roles, organ-specific pathogenesis, and therapeutic implications Lin Chen, Guorui Li, Mingqiong Tong, Na Song, Yaru Jin, Dan Wang, Yanyan Zhao, Xueting Yang, Yaqing Ge, Sha Liu, Xiangling Gu Burns.2026; 52(7): 108078. CrossRef
P38γ drives aerobic glycolysis in liver sinusoidal endothelial cells and regulates alcoholic liver disease via the PFKFB3 signaling pathway Qian Zhang, Miao Yang, Yun Zhang, Jing Hu Molecular Biology Reports.2026;[Epub] CrossRef
Sinusoidal endothelial cells control liver inflammation and fibrosis Yingfen Chen, Yong He Journal of Clinical Investigation.2026;[Epub] CrossRef
Nuclear translocation of GPS2 promotes activation of hepatic stellate cells by fatty acid oxidation pathway Haiqin Hong, Li Wang, Muran Lu, Ziyi An, Yanxia Shi, Qi Deng, Jingjing Wu, Benwei Wang, Jialu Lu, Mengjun Li, Yan Huang, Weili Lu, Fanrong Wu Life Sciences.2026; 401: 124529. CrossRef
Mutually Reinforcing Polyphenol and Nanomedicines: Unlocking the Potential of Polyphenol‐Based Nanodrugs for Liver Injury Therapy Min Liu, Rui Huang, Shuya Wang, Yuting Lin, Tingli Xiong, Ruishi Li, Wenxuan Zheng, Qiong Huang, Yayun Nan, Zhaoqian Liu, Kelong Ai Advanced Healthcare Materials.2026;[Epub] CrossRef
Emerging metabolic hormone therapeutics for metabolic dysfunction-associated steatohepatitis: incretin-based drugs, fibroblast growth factor analogs, and liver-targeting strategies Sukwoo Han, Jaehee Shin, Jae Cheon Kim, Dong Hee Na Journal of Pharmaceutical Investigation.2026;[Epub] CrossRef
Hyaluronic acid-coated metal–organic framework for co-delivery of Sirtuin 3 gene and zinc to inhibit liver fibrosis Jisun Jung, Minyoung Jin, Naeun Park, Hani Choi, Kun Na Acta Biomaterialia.2026;[Epub] CrossRef
Vascularized tumor organoids as models for interpreting therapeutic response Shanshan Huang, Sen Han, Kai Wang Vascular Pharmacology.2026; 164: 107673. CrossRef
Mannose receptor-targeted MSC-derived exosomes as a high-affinity delivery platform for liver sinusoidal endothelial cells Ji Won Lee, Jin Suk Lee, Kangchan Choi, Mi Ra Lee, Seul Ki Han, Soon Koo Baik, Yong Serk Park, Moon Young Kim Drug Delivery and Translational Research.2026;[Epub] CrossRef
Natural Flavonoids as Potential Modulators of Liver Fibrosis: A Review of Mechanisms and Therapeutic Targets Jia Liu, Yi Han, Lingli Chen, Yifei Chen, Haiping Liang, Hui Chen, Wenbing Hu, Suyun Lin, Wenjun Wang Journal of Future Foods.2026;[Epub] CrossRef
Spermidine suppresses liver fibrosis by remodeling the communication signal between liver sinusoidal endothelial cells and hepatic stellate cells Cheng Zeng, Jiao Liu, Zhiqiang Jin, Shan Zhong, Rong Wu, Haoyue Luo, Tao Zeng, Yang Yang, Zhi Zhou Cell Death Discovery.2026;[Epub] CrossRef
Recent advances of nanomaterials in imaging liver fibrosis Jin Cui, Shuxuan Zhang, Xueli Xu, Ke Ren, Mengzhen Dong, Zhaokun Nie, Yang Xu, Xiaohui Dai, Peng Xu, Shuo Sun, Xinya Zhao, Xiao Sun BMEMat.2025;[Epub] CrossRef
Immune Checkpoints and the Immunology of Liver Fibrosis Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis Livers.2025; 5(1): 5. CrossRef
Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension Yanqiu Li, Bingbing Zhu, Ke Shi, Yu Lu, Xuanwei Zeng, Yongqi Li, Qun Zhang, Ying Feng, Xianbo Wang Frontiers in Medicine.2025;[Epub] CrossRef
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics Xiao Ma, Tengda Huang, Xiangzheng Chen, Qian Li, Mingheng Liao, Li Fu, Jiwei Huang, Kefei Yuan, Zhen Wang, Yong Zeng Signal Transduction and Targeted Therapy.2025;[Epub] CrossRef
Injury and Fibrosis at the Myoaponeurotic Junction of Pectoralis Major and Supracoracoideus Muscles in Broiler Chickens Takeshi Kawasaki, Tomohito Iwasaki, Takafumi Watanabe, Michi Yamada, Naoyuki Maeda, Yasuhiro Hasegawa, Naoki Takahashi, Ryosuke Kobayashi The Journal of Poultry Science.2025; 62: n/a. CrossRef
Sulfur dioxide-releasing nanomotors improve the therapeutic effect of liver fibrosis by restoring the fenestrae of sinusoids Lin Chen, Zhengwei Chen, Di Shi, Haifeng Ke, Chun Mao, Mimi Wan Journal of Colloid and Interface Science.2025; 692: 137557. CrossRef
Reconstructing the hepatocellular carcinoma microenvironment: the current status and challenges of 3D culture technology Ting Xiong, Kai Wang Discover Oncology.2025;[Epub] CrossRef
Liver Sinusoidal Endothelial Cells in the Regulation of Immune Responses and Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease Munish Puri, Snehal Sonawane International Journal of Molecular Sciences.2025; 26(9): 3988. CrossRef
Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma Young-Min Jee, Jeong-Yoon Lee, Tom Ryu Biomedicines.2025; 13(5): 1260. CrossRef
Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective Xiangchang Zeng, Deliang Huang, Zhibin Zhu, Qingxian Cai, Yang Yang, Hongzhou Lu, Jun Chen Frontiers in Pharmacology.2025;[Epub] CrossRef
Targeting endoplasmic reticulum proteostasis in liver fibrosis: From signaling mechanisms to therapeutic opportunities Yawei Kong, Zhengyang Chen, Zhentian Nie, Wei Chen Pharmacological Research.2025; 217: 107823. CrossRef
Reactive oxygen species-responsive micelles targeting activated hepatic stellate cells for treating liver fibrosis Xin Yu Liu, He Ying Mao, Jun Sheng Hu, Tong Rui Dou, Ben Chi Liu, Chang Xiu Lin, Cheng-Hua Jin, Ming Guan Piao Journal of Controlled Release.2025; 385: 113997. CrossRef
Liver Sinusoidal Endothelial Cells and Their Regulation of Immunology, Collagenization, and Bioreactivity in Fatty Liver: A Narrative Review Reem J. Abdulmajeed, Consolato M. Sergi International Journal of Molecular Sciences.2025; 26(16): 8006. CrossRef
From cooperation to collapse: systemic failure in liver disease through a sociological lens Junyu Wang, Jingting Lei, Martin C. Harmsen, Han Moshage Exploration of Digestive Diseases.2025;[Epub] CrossRef
Anogeissus leiocarpus (DC.) Guill. & Perr. extract-protected rats against CCl4-induced liver fibrosis Omokolade O. Alejolowo, Olarewaju M. Oluba, Oluyomi S. Adeyemi Journal of Taibah University Medical Sciences.2025; 20(4): 474. CrossRef
Anti-hepatic fibrosis activity and mechanisms of natural polysaccharides: A comprehensive review Xing Yang, Mingyi Shao, Ruixia Zhao, Rui Li, Bingzhao Du, Qian Bi, Yanan Liu, Hongyan Cui International Journal of Biological Macromolecules.2025; 328: 147678. CrossRef
YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling Junjun Wang, Zhenyang Shen, Guangwen Chen, Weiming Dai, Zhu Mei, Bo Shen, Yuecheng Guo, Jianxiang Wang, Hanjing Zhangdi, Qingqing Zhang, Jiaqi Gao, Qichao Ge, Hui Zhou, Hui Dong, Lungen Lu, Xiaobo Cai Cellular & Molecular Biology Letters.2025;[Epub] CrossRef
Genomic medicine in hepatology: mechanisms and liver treatment strategies D. S. Kozlov, S. Rodimova, P. Filatov, A. Mozherov, P. S. Timashev, M. V. Zyuzin, D. S. Kuznetsova Molecular Medicine.2025;[Epub] CrossRef
Piezo-mediated mechanically activated currents in organ fibrosis: Novel mechanisms and therapeutic strategies Ling Dong, Li-Chan Lin, Sui Mao, Zhen-Yu Liu, Peng Liu, Rui Li, Hui Tao, Ye Zhang Life Sciences.2025; 382: 124050. CrossRef
Retinal Sensitivity Loss and Beyond in KCNV2-Related Retinopathy: The First Genetically Confirmed Case in Türkiye Özlem Ural Fatihoğlu, Ayşe Bozkurt Oflaz, Özlem Özkan, Hande Taylan Şekeroğlu, Ali Osman Saatçi Turkish Journal of Ophthalmology.2025; 55(6): 352. CrossRef
Transcriptome Analyses of Liver Sinusoidal Endothelial Cells Reveal a Consistent List of Candidate Genes Associated with Endothelial Dysfunction and the Fibrosis Progression Penghui Li, Wenjie Xie, Hongjin Wei, Fan Yang, Yan Chen, Yinxiong Li Current Issues in Molecular Biology.2024; 46(8): 7997. CrossRef
Correspondence to editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis” Jiaorong Qu, Le Wang, Xiaojiaoyang Li Clinical and Molecular Hepatology.2024; 30(4): 1002. CrossRef
Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis” Yasuko Iwakiri Clinical and Molecular Hepatology.2024; 30(4): 673. CrossRef
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease Hui Gao, Yanchao Jiang, Ge Zeng, Nazmul Huda, Themis Thoudam, Zhihong Yang, Suthat Liangpunsakul, Jing Ma eGastroenterology.2024; 2(4): e100104. CrossRef
Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease Ana Paula Madariaga Traconis, Misael Uribe-Esquivel, Varenka Julieta Barbero Becerra Cells.2024; 13(24): 2055. CrossRef
Si-Wu-Tang improves liver fibrosis by restoring liver sinusoidal endothelial cell functionality and reducing communication with hepatic stellate cells Le Wang, Jiaorong Qu, Jianan Li, Xiaoyong Xue, Lingling Qin, Yufei Li, Yuanfeng Dou, Xiaohong Mu, Xiaojiaoyang Li Chinese Medicine.2024;[Epub] CrossRef
First
Prev
